S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Gary A. Lyons to Join Cytori Therapeutics’ Board of Directors (2013/10/9)|
|Cytori Reports First Half and 2nd Quarter 2013 Business and Financial Results ()|
|Cytori Divests Puregraft® Products, Licenses Celution® for Alopecia and Options Broader Aesthetic Market Rights ()|
|Cytori’s Celution® System Approved in Australia for Processing and Delivering Adipose-Derived Regenerative Cells (2013/8/7)|
|Cytori to Webcast Second Quarter Financial Results on August 8 ()|
|Cytori Therapeutics Announces Participation at the 2013 Stem Cell Meeting on the Mesa’s 3rd Annual Regen Med Partnering Forum on October 14th and 15th (2013/10/8)|
|Cytori Reports Nine Month and Third Quarter 2013 Business and Financial Results (2013/11/7)|
|Cytori Patents Adipose-Derived Cell Therapy for Cardiovascular Disease in Australia (2013/10/10)|
|Cytori Comments on New Legislation for Regenerative Medicine in Japan (2013/11/21)|
|Cytori Obtains Celution® System Approval in Singapore (2013/10/7)|
Click above to view more mutual fund data and stats for cytx - Cytori Therapeutics, Inc..